Article
A Tissue-Bioengineering Strategy for Modeling Rare Human Kidney Diseases <i>In Vivo</i>
2021-10-20
Abstract excerpt
<h4>ABSTRACT</h4> The lack of animal models for certain human diseases precludes our understanding of disease mechanisms and our ability to test new therapies in vivo . Here we generated kidney organoids from Tuberous Sclerosis Complex (TSC) patient-derived-hiPSCs to recapitulate a rare kidney tumor called angiomylipoma (AML). Organoids derived from TSC2 -/- hiPSCs but not from isogenic TSC2 +/- or TSC2 +/+ h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fc65ee6-b279-56bf-ba0a-b04feadf61cd
- DOI
- 10.1101/2021.10.20.465120
